- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
J&J's Janssen Pharmaceuticals will oppose Florida's use of its drug in a Thursday execution.
Cantor Fitzgerald says Allscripts acquisition of McKesson's Enterprise Information Solutions will provide it material cost saving opportunities.
It's been a rough week for McKesson.